Ad is loading...
JABCX
Price
$47.29
Change
-$0.51 (-1.07%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

JABCX vs RLEFX

Header iconJABCX vs RLEFX Comparison
Open Charts JABCX vs RLEFXBanner chart's image
Janus Henderson Balanced C
Price$47.29
Change-$0.51 (-1.07%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
JABCX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JABCX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABCX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. JABCX (26B). RLEFX pays higher dividends than JABCX: RLEFX (2.42) vs JABCX (1.08). JABCX was incepted earlier than RLEFX: JABCX (15 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. JABCX (92.00). RLEFX has a lower initial minimum investment than JABCX: RLEFX (250) vs JABCX (2500). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. JABCX (19.89). JABCX (36.06) and RLEFX (35.95) have equivalent 5 years return.
JABCXRLEFXJABCX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years9 years-
Gain YTD14.37614.211101%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets26B236B11%
Annual Yield % from dividends1.082.4245%
Returns for 1 year19.8921.0994%
Returns for 3 years4.2310.9539%
Returns for 5 years36.0635.95100%
Returns for 10 years62.59N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology